The wielder of the evil eye, the jettatore, is described as having a striking facial appearance, high arching brows with a stark stare that leaps from his eyes. He often has a reputation for clandestine involvement with dark powers and is the object of gossip about dealings in magic and other forbidden practices. Successful men having tremendous personal magnetism quickly gain notoriety as jettatori. Pope Pius IX was dreaded for his evil eye, and a whole cycle of stories about the disasters that happened in his wake were current in Rome during the latter decades of the 19th century. Public figures of every type, from poets to gangsters, have had their specialized abilities attributed to the power of their eyes. Malta
The symbol of the eye, known as "l-għajn", is common on traditional fishing boats which are known as luzzu. They are said to protect fishermen from storms and malicious intentions. Brazil
Brazilians generally will associate mau-olhado ("act of giving a bad look") or olho gordo ("fat eye" i.e. "gluttonous eye") with envy or jealousy on domestic and garden plants (that, after months or years of health and beauty, will suddenly weaken, wither and die, with no apparent signs of pest, after the visitation of a certain friend or relative), attractive hair and less often economic or romantic success and family harmony. Unlike in most cultures mau-olhado is not seen to be something that risks young babies.
In the US the medication was approved for all people with ALS but it was unclear at approval whether insurers would agree to pay for the medication for all people with ALS, or only people in the early stages of the disease. There are three filed trials for edaravone, demonstrating it may work in less than 5% of all ALS population. Brand names
Brand names include Radicut, ラジカット, Radicava, Xavron. References
Further reading
Yoshino H (March 2019). "Edaravone for the treatment of amyotrophic lateral sclerosis". Expert Rev Neurother. 19 (3): 185–193. doi:10.1080/14737175.2019.1581610. PMID 30810406. S2CID 73490631. Canadian Agency for Drugs and Technologies in Health (April 2019). Pharmacoeconomic Review Report: Edaravone (Radicava): (Mitsubishi Tanabe Pharma Corporation). CADTH Common Drug Reviews. PMID 31211530. NBK542526. External links
"Edaravone". Drug Information Portal. U.S. National Library of Medicine.